ערך בספרים למניה: Pulse Corp (PLSE)

The success of Pulse Biosciences, Inc. (PLSE) depends on the outcomes of tests for its innovative ablation system and the capital-intensive process of bringing the product to market. Pulse Biosciences, Inc. (PLSE) is introducing current into dermatology, creating a steady stream of orders for services and components. This market valuation on GURU.Markets is currently fixed at 1.41. Brand loyalty is growing due to nanosecond pulses and the proven effectiveness of the method.

Pulse Biosciences, Inc. (PLSE) is developing automated nanosecond electroporation systems for precision tissue therapy. Analyzing the historical book value per share chart allows for a real-time assessment of the tangible asset backing of this high-tech business. This metric is calculated as the difference between total assets and liabilities, divided by the number of shares outstanding. A downward trend signals capital dilution or asset write-downs, while steady growth confirms the asset's intrinsic value.